December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Euda Health Holdings Limited - Ordinary Shares (NQ:EUDA)

2.285 -0.055 (-2.35%)
Streaming Delayed Price Updated: 9:54 AM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Euda Health Holdings Limited - Ordinary Shares

News headline image
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health to Launch EUDA Helixé 2.0 in January 2026
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Signs Letter of Intent to Potentially Acquire GO POSB
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
From EUDA Health Holdings Ltd
Via GlobeNewswire
News headline image
8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination
From EUDA Health Holdings Limited
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.